| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CDNA | CareDx, Inc. | Hannah Valantine | Director | Jul 16, 2026 | Option/RSU Exercise | $14.76 | 28,779 | 424,895 | 65,465 | Jul 17, 2026, 04:22 PM | |
| CDNA | CareDx, Inc. | Hannah Valantine | Director | Jul 16, 2026 | Sale | $36.15 | 28,779 | 1,040,243 | 36,786 | Jul 17, 2026, 04:22 PM | |
| BBIO | BridgeBio Pharma, Inc. | Hannah Valantine | Director | Jun 22, 2026 | Sale | $68.00 | 2,808 | 190,944 | 11,455 | Jun 24, 2026, 06:06 PM | |
| BBIO | BridgeBio Pharma, Inc. | Hannah Valantine | Director | Jun 23, 2026 | Sale | $68.57 | 2,196 | 150,580 | 9,259 | Jun 24, 2026, 06:06 PM | |
| BBIO | BridgeBio Pharma, Inc. | Hannah Valantine | Director | Jun 22, 2026 | Option/RSU Exercise | $41.73 | 2,808 | 117,178 | 14,263 | Jun 24, 2026, 06:06 PM | |
| CDNA | CareDx, Inc. | Hannah Valantine | Director | Jun 15, 2026 | Sale | $23.11 | 12,103 | 279,728 | 36,686 | Jun 16, 2026, 05:51 PM | |
| BBIO | BridgeBio Pharma, Inc. | Hannah Valantine | Director | Mar 10, 2026 | Option/RSU Exercise | $27.36 | 8,671 | 237,239 | 16,136 | Mar 12, 2026, 04:15 PM | |
| BBIO | BridgeBio Pharma, Inc. | Hannah Valantine | Director | Mar 10, 2026 | Sale | $72.00 | 8,671 | 624,312 | 7,465 | Mar 12, 2026, 04:15 PM | |
| BBIO | BridgeBio Pharma, Inc. | Hannah Valantine | Director | Nov 12, 2025 | Option/RSU Exercise | $48.45 | 25,484 | 1,234,700 | 32,949 | Nov 14, 2025, 04:50 PM | |
| BBIO | BridgeBio Pharma, Inc. | Hannah Valantine | Director | Nov 12, 2025 | Sale | $66.07 | 25,484 | 1,683,728 | 7,465 | Nov 14, 2025, 04:50 PM | |
| BBIO | BridgeBio Pharma, Inc. | Hannah Valantine | Director | Jun 26, 2025 | Sale | $44.05 | 2,418 | 106,504 | 9,007 | Jun 30, 2025, 05:51 PM | |
| BBIO | BridgeBio Pharma, Inc. | Hannah Valantine | Director | Jun 26, 2025 | Sale | $44.05 | 2,289 | 100,824 | 2,289 | Jun 30, 2025, 05:51 PM | |
| BBIO | BridgeBio Pharma, Inc. | Hannah Valantine | Director | Dec 29, 2021 | Buy | $14.24 | 1,752 | 24,948 | 3,294 | Jun 30, 2025, 05:49 PM | |
| BBIO | BridgeBio Pharma, Inc. | Hannah Valantine | Director | Dec 28, 2021 | Buy | $12.68 | 1,542 | 19,553 | 1,542 | Jun 30, 2025, 05:46 PM | |
| BBIO | BridgeBio Pharma, Inc. | Hannah Valantine | Director | Dec 28, 2021 | Buy | $13.16 | 796 | 10,475 | 2,687 | Jun 30, 2025, 05:46 PM | |
| CDNA | CareDx, Inc. | Hannah Valantine | Director | Jun 18, 2025 | Sale | $19.16 | 10,570 | 202,566 | 38,994 | Jun 23, 2025, 04:30 PM | |
| BBIO | BridgeBio Pharma, Inc. | Hannah Valantine | Director | Jun 10, 2025 | Option/RSU Exercise | $16.75 | 4,292 | 71,891 | 6,056 | Jun 11, 2025, 05:00 PM | |
| BBIO | BridgeBio Pharma, Inc. | Hannah Valantine | Director | Jun 10, 2025 | Sale | $40.00 | 4,292 | 171,680 | 1,764 | Jun 11, 2025, 05:00 PM | |
| BBIO | BridgeBio Pharma, Inc. | Hannah Valantine | Director | Mar 06, 2025 | Option/RSU Exercise | $16.75 | 12,875 | 215,656 | 14,639 | Mar 10, 2025, 04:43 PM | |
| BBIO | BridgeBio Pharma, Inc. | Hannah Valantine | Director | Mar 06, 2025 | Sale | $32.58 | 12,875 | 419,500 | 1,764 | Mar 10, 2025, 04:43 PM | |
| BBIO | BridgeBio Pharma, Inc. | Hannah Valantine | Director | Feb 15, 2024 | Option/RSU Exercise | $8.45 | 2,915 | 24,632 | 4,679 | Feb 20, 2024, 04:03 PM | |
| BBIO | BridgeBio Pharma, Inc. | Hannah Valantine | Director | Feb 15, 2024 | Sale | $37.75 | 2,915 | 110,041 | 1,764 | Feb 20, 2024, 04:03 PM | |
| BBIO | BridgeBio Pharma, Inc. | Hannah Valantine | Director | Dec 28, 2021 | Buy | $12.96 | 3,433 | 44,476 | 3,433 | Feb 13, 2024, 04:00 PM | |
| BBIO | BridgeBio Pharma, Inc. | Hannah Valantine | Director | Jan 16, 2024 | Option/RSU Exercise | $8.45 | 2,915 | 24,632 | 4,679 | Jan 18, 2024, 04:10 PM | |
| BBIO | BridgeBio Pharma, Inc. | Hannah Valantine | Director | Jan 16, 2024 | Sale | $37.97 | 2,915 | 110,683 | 1,764 | Jan 18, 2024, 04:10 PM | |
| BBIO | BridgeBio Pharma, Inc. | Hannah Valantine | Director | Dec 15, 2023 | Sale | $36.12 | 2,915 | 105,290 | 1,764 | Dec 19, 2023, 04:00 PM | |
| BBIO | BridgeBio Pharma, Inc. | Hannah Valantine | Director | Dec 15, 2023 | Option/RSU Exercise | $8.45 | 2,915 | 24,632 | 4,679 | Dec 19, 2023, 04:00 PM | |
| BBIO | BridgeBio Pharma, Inc. | Hannah Valantine | Director | Nov 15, 2023 | Option/RSU Exercise | $8.45 | 2,915 | 24,632 | 4,679 | Nov 17, 2023, 04:09 PM | |
| BBIO | BridgeBio Pharma, Inc. | Hannah Valantine | Director | Nov 15, 2023 | Sale | $30.00 | 2,915 | 87,450 | 1,764 | Nov 17, 2023, 04:09 PM | |
| BBIO | BridgeBio Pharma, Inc. | Hannah Valantine | Director | Dec 29, 2021 | Buy | $14.23 | 1,764 | 25,102 | 1,764 | Jan 03, 2022, 07:53 PM |
